Atara Biotherapeutics, Inc.

ATRA Nasdaq CIK: 0001604464

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Mailing Address 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Phone 805-623-4211
Fiscal Year End 1231
EIN 460920988

Financial Overview

FY2024 FY

$128.94M
Revenue
-$85.40M
Net Income
$264.74M
Total Liabilities
$126.64M
Stockholders' Equity
$25.84M
Cash & Equivalents
$-11.41
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13D/A Beneficial ownership amendment January 14, 2026 View on SEC
4 Insider stock transaction report January 14, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
8-K Current report of material events January 2, 2026 View on SEC
4 Insider stock transaction report December 1, 2025 View on SEC
4 Insider stock transaction report November 19, 2025 View on SEC
4 Insider stock transaction report November 19, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 14, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment November 14, 2025 View on SEC
8-K Current report of material events November 12, 2025 View on SEC

Insider Trading

STRONG SELL 3 insiders 6 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.